1
Gholamreza Sheikhnehjad, Mina Patel Sooch, Neal Goodwin, David Olson: Methods and compositions for the inhibition of gene expression. ProNAI Therapeutics, Honigman Miller, Jonathan P O Brien, Kelly T Murphy, March 3, 2009: US07498315 (4 worldwide citation)


The present invention relates to methods and compositions for the inhibition of gene expression. In particular, the present invention provides oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers.


2
Gholamreza Sheikhnehjad, Mina Patel Sooch, Neal Clifford Goodwin, David Olson: Methods and compositions for the inhibition of gene expression. ProNAi Therapeutics, Honigman Miller Schwartz & Cohn, Kelly T Murphy, Jonathan P O Brien, August 26, 2014: US08815599 (1 worldwide citation)


The present invention relates to methods and compositions for the inhibition of gene expression. In particular, the present invention provides oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers.


3
Gholamreza Sheikhnehjad, Mina Patel Sooch, Neal Goodwin, David Olson: Methods and compositions for the inhibition of gene expression. PRONAI THERAPEUTICS, Fenwick & West, July 19, 2016: US09393258


The present invention relates to methods and compositions for the inhibition of gene expression. In particular, the present invention provides oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers.


4
Gholamreza Sheikhnehjad, Mina Patel Sooch, Neal Goodwin, David Olson: Methods and compositions for the inhibition of gene expression. ProNAi Therapeutics, Tanya A Arenson, Medlen & Carroll, April 6, 2006: US20060073596-A1


The present invention relates to methods and compositions for the inhibition of gene expression. In particular, the present invention provides oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers.


5
Gholamreza Sheikhnehjad, Mina Patel Sooch, Neal Goodwin, David Olson: Methods and Compositions for the Inhibition of Gene Expression. Pronai Therapeutics, June 9, 2011: US20110135710-A1


The present invention relates to methods and compositions for the inhibition of gene expression. In particular, the present invention provides oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers.



Click the thumbnails below to visualize the patent trend.